Stock Market, Economics, Equity Analysis
Feb28
Valeant Pharmaceuticals (VRX) is an interesting roll up company in the pharma space; the entity was formed by a mega merger of of Valeant and Biovail in late 2010 to form this $16B player. The stock has been quite weak of…